Iron acquisition by the genus mycobacterium : history, mechanisms, role of siderocalin, anti-tuberculosis drug development / edited by B. Rowe Byers
Contributor(s): Byers, B. Rowe, editor literario
Material type:
E-bookSeries: Publisher: Heidelberg : Springer International Publishing, 2013Description: 1 recurso en línea (V, 92 p.) : 39 ilustraciones, 9 ilustraciones en color.ISBN: 9783319003030.Subject: Micobacterias
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | QR82 .M8 I76 2013 EB (Browse shelf(Opens below)) | .i11547431 | Acceso electrónico | eBOOK .i11547431 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| QR82 .M8 2015 EB Mycobacteria Protocols | QR82.M8 2020 EB Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids | QR82.M8 2023 EB Diagnosis of Mycobacterium | QR82 .M8 I76 2013 EB Iron acquisition by the genus mycobacterium : history, mechanisms, role of siderocalin, anti-tuberculosis drug development | QR82 .N4 2001 EB Meningococcal Disease | QR82.N4 A383 2016 EB Advances in Understanding Kingella kingae | QR82 .P74 2006 EB Pseudomonas |
A History of Iron Metabolism in the Mycobacteria -- Mycobacterial Iron Uptake Mechanisms -- Siderocalin Combats Mycobacterial Infections -- Design of Anti-TB Drugs Using the Iron Uptake Platform
Iron Acquisition by the Genus Mycobacterium summarizes the early evidence for the necessity of iron in mycobacteria and the discovery of the mycobacterial siderophores mycobactin, carboxymycobactin, and exochelin. The structural characterization of the mycobacterial siderophores is described. The genes so far identified as essential for iron acquisition and maintenance of an infection by pathogenic mycobacteria are discussed. The potential role of siderocalin in iron gathering by M. tuberculosis is featured. Because new drugs for M. tuberculosis are needed, this brief also emphasizes the design of antibiotics that interfere with siderophore biosynthesis and the use of siderophore analogs and/or conjugates
There are no comments on this title.